Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease.

Subjects

Subjects :

*INFLAMMATORY bowel diseases
*VEDOLIZUMAB
*CROHN'S disease
*DISEASE remission
*GASTROINTESTINAL agents
*LONGITUDINAL method
*MONOCLONAL antibodies
*SPONDYLOARTHROPATHIES
*TREATMENT effectiveness
*RETROSPECTIVE studies
*DISEASE complications

Details

Language :

English

ISSN :

1297319X

Volume :

86

Issue :

5

Database :

Academic Search Index

Journal :

Joint Bone Spine

Publication Type :

Academic Journal

Accession number :

139075161

Full Text :

https://doi.org/10.1016/j.jbspin.2019.01.008